Season 9, Episode 12 - Collaborating across disciplines to find the best solution for people living with PBC
This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC). Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.
Faculty: David Jones (Moderator), Marco Carbone (Faculty), Bettina Hansen (Faculty), Ana Lleo (Faculty)
This EASL Studio is supported by Advanz Pharma, Gilead Sciences Europe Ltd, GSK, Intercept, IPSEN and Mirum. EASL has received no input from Advanz Pharma, Gilead Sciences Europe Ltd, GSK, Intercept, IPSEN or Mirum with regards to the content of this programme.
Add event to calendar
